Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

被引:4
|
作者
Patlolla, Sri Harsha [1 ]
Schaff, Hartzell V. [1 ]
Nishimura, Rick A. [2 ]
Eleid, Mackram F. [2 ]
Geske, Jeffrey B. [2 ]
Ommen, Steve R. [2 ]
机构
[1] Mayo Clin, Dept Cardiovasc Surg, 200 First Street SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
来源
关键词
disparities; ethnicity; hypertrophic cardiomyopathy; race; septal reduction; MYECTOMY; ABLATION; VOLUME;
D O I
10.1161/JAHA.122.026661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundInformation on impact of race and ethnicity on use and early outcomes of septal reduction therapies (SRTs) for obstructive hypertrophic obstructive cardiomyopathy are limited. Methods and ResultsUsing the National Inpatient Sample from January 2012 through December 2019, we identified all adult admissions with a primary diagnosis of obstructive hypertrophic cardiomyopathy and those undergoing SRT. Predictors of receiving SRT and outcomes including in-hospital mortality, complications, and resource use were evaluated in racial and ethnic groups. Among a total of 18 895 adult admissions with obstructive hypertrophic cardiomyopathy, SRT was performed in 7255 (38.4%) admissions. Septal myectomy was performed in 4930 (26.1%), while alcohol septal ablation was performed in 2325 (12.3%). In adjusted analysis, Black patient (versus White patient adjusted odds ratio, 0.65 [95% CI, 0.57-0.73]; P<0.001) and Hispanic patient admissions (versus White adjusted odds ratio, 0.78 [95% CI, 0.66-0.92]; P=0.003) were less likely to receive SRT. Among admissions undergoing SRT, in-hospital mortality was significantly higher for Hispanic (adjusted odds ratio, 3.38 [95% CI, 1.81-6.30], P<0.001) and other racial and ethnic groups (adjusted odds ratio 2.02 [95% CI, 1.00-4.11]; P=0.05) compared with White patient admissions, whereas Black patient admissions had comparable mortality. Black, Hispanic, and other ethnic group patients had higher rates of SRT complications and more frequent dismissals to acute care facilities. ConclusionsAmong obstructive hypertrophic cardiomyopathy hospitalizations, minoritized racial groups were less likely to receive SRT. Importantly, hospitalizations of Hispanic and other ethnic patients undergoing SRT had significantly higher in-hospital mortality and complication rates. Further studies with granular echocardiographic information to assess indications for SRT are needed to better understand these differences.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Sex Disparities in the Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
    Diaz-Arocutipa, Carlos
    Moreno, Guillermo
    Giraldez, Manuel
    Hernandez, Adrian, V
    Mamas, Mamas A.
    Vicent, Lourdes
    CJC OPEN, 2024, 6 (09) : 1108 - 1115
  • [2] Sex Differences in the Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
    Sreenivasan, Jayakumar
    Khan, Muhammad Shahzeb
    Kaul, Risheek
    Bandyopadhyay, Dhrubajyoti
    Hooda, Urvashi
    Aronow, Wilbert S.
    Cooper, Howard A.
    Panza, Julio A.
    Naidu, Srihari S.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (08) : 930 - 932
  • [3] Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy
    Patel, Nirav
    Shetty, Naman
    Gaonkar, Mokshad
    Shahid, Abdulla
    Divekar, Girija
    Pampana, Akhil
    Vekariya, Nehal
    Peng, Li
    Ahmed, Mustafa
    Arora, Garima
    Arora, Pankaj
    CIRCULATION, 2024, 150
  • [4] Procedural Volume and Outcomes of Septal Reduction Therapies in Patients With Hypertrophic Obstructive Cardiomyopathy
    Panaich, Sidakpal S.
    Chothani, Ankit
    Badheka, Apurva O.
    JAMA CARDIOLOGY, 2017, 2 (01) : 110 - 111
  • [5] Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy
    Patel, Nirav
    Shetty, Naman S.
    Gaonkar, Mokshad
    Shahid, Abdulla
    Divekar, Girija P.
    Pampana, Akhil
    Vekariya, Nehal
    Li, Peng
    Ahmed, Mustafa I.
    Arora, Garima
    Arora, Pankaj
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (21):
  • [6] Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy
    Patel, Nirav
    Shetty, Naman
    Gaonkar, Mokshad
    Shahid, Abdulla
    Pampana, Akhil
    Li, Peng
    Ahmed, Mustafa
    Arora, Garima
    Arora, Pankaj
    JOURNAL OF CARDIAC FAILURE, 2024, 30 : S7 - S7
  • [7] IMPACT OF PULMONARY HYPERTENSION ON SEPTAL REDUCTION THERAPY OUTCOMES FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Isath, Ameesh
    Lanier, Gregg M.
    Spielvogel, David
    Malekan, Ramin
    Steinmetz, Carolyn
    Semaan, Rosa
    Fishkin, Tzvi
    Panza, Julio A.
    Naidu, Srihari S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 549 - 549
  • [8] Procedural Volume and Outcomes of Septal Reduction Therapies in Patients With Hypertrophic Obstructive Cardiomyopathy-Reply
    Kim, Luke K.
    Feldman, Dmitriy N.
    JAMA CARDIOLOGY, 2017, 2 (01) : 111 - 111
  • [9] SEX DIFFERENCES IN PATIENT SELECTION AND OUTCOMES OF SEPTAL REDUCTION THERAPIES FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN THE UNITED STATES
    Sreenivasan, Jayakumar
    Hooda, Urvashi
    Kaur, Simrat
    Sharma, Sachit
    Aronow, Wilbert S.
    Cooper, Howard A.
    Naidu, Srihari
    Panza, Julio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 949 - 949
  • [10] Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy
    Cavigli, Luna
    Fumagalli, Carlo
    Maurizi, Niccolo
    Rossi, Alessandra
    Arretini, Anna
    Targetti, Mattia
    Passantino, Silvia
    Girolami, Francesca
    Tomberli, Benedetta
    Baldini, Katia
    Tomberli, Alessia
    Antoniucci, David
    Yacoub, Magdi H.
    Marchionni, Niccolo
    Stefano, Pier Luigi
    Cecchi, Franco
    Olivotto, Iacopo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 155 - 161